0001610717-24-000094.txt : 20240228
0001610717-24-000094.hdr.sgml : 20240228
20240228172913
ACCESSION NUMBER: 0001610717-24-000094
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240227
FILED AS OF DATE: 20240228
DATE AS OF CHANGE: 20240228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Martell Bridget A
CENTRAL INDEX KEY: 0001629627
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39617
FILM NUMBER: 24697285
MAIL ADDRESS:
STREET 1: C/O POINT BIOPHARMA GLOBAL INC.
STREET 2: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aligos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001799448
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE CORPORATE DR., 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (800) 466-6059
MAIL ADDRESS:
STREET 1: ONE CORPORATE DR., 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4.xml
X0508
4
2024-02-27
0001799448
Aligos Therapeutics, Inc.
ALGS
0001629627
Martell Bridget A
C/O ALIGOS THERAPEUTICS, INC.
1 CORPORATE DRIVE, 2ND FLOOR
SOUTH SAN FRANCISCO
CA
94080
true
false
Stock Option (Right to Buy)
16.52
2024-02-27
4
D
0
30000
0
D
2021-12-16
2031-11-16
Common Stock
30000
0
D
Stock Option (Right to Buy)
0.96
2024-02-28
4
A
0
8823
0
A
2031-11-16
Common Stock
8823
8823
D
On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 30,000 of the issuer's shares granted to the reporting person on November 16, 2021. In exchange, on February 28, 2024, the reporting person received a replacement option, for 8,823 shares, having an exercise price of $0.96 per share.
The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary.
/s/ Lesley Ann Calhoun, as attorney-in fact for Bridget Martell
2024-02-28